🇺🇸 FDA
Pipeline program

Group A

BR-BST06-001

Phase 1 mab active

Quick answer

Group A for Hepatocellular Carcinoma is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatocellular Carcinoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials